Patents by Inventor Carl Wagner

Carl Wagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240118283
    Abstract: The present invention relates to, inter alia, engineered microorganisms expressing (i) a surface protein, which specifically interacts cell membrane receptors that are specifically exposed to the luminal side of epithelial cells of diseased gastrointestinal tissue, and (ii) a secretable biomarker. The engineered bacteria of the present technology are useful for detecting diseased gastrointestinal tissue.
    Type: Application
    Filed: December 8, 2023
    Publication date: April 11, 2024
    Inventors: Jeffrey Wagner, Fred H. Mermelstein, Carl D. Novina, Robert Distel, Steven Neier, Barry Polisky
  • Patent number: 11458203
    Abstract: The present disclosure relates to pharmaceutical compositions comprising caffeic acid chelates, kits, and methods for using such compounds and pharmaceutical compositions.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: October 4, 2022
    Assignee: Arizona Board of Regents on behalf of Arizona State University
    Inventors: Thomas Cahill, Jeffrey Langland, Bertram Jacobs, Carl Wagner, Guillermo Ruiz
  • Publication number: 20220259157
    Abstract: The present invention relates to compositions comprising an RXR agonist, an RAR agonist, or a dual RXR/RAR agonist. The present invention further relates to methods of using the agonist compositions for treating or preventing dementia and cancer. In some embodiments, the dementia comprises Alzheimer's disease. In some embodiments, the cancer comprises leukemia.
    Type: Application
    Filed: June 24, 2020
    Publication date: August 18, 2022
    Inventors: Carl Wagner, Pamela Marshall, Peter Jurutka
  • Patent number: 10787421
    Abstract: The invention provides compounds formula (I) and salts thereof: wherein R1-R4 have any of the values defined in the specification. The compounds are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, inflammation, hyperresponsiveness, allergic conditions, asthma, and psychotic disorders such as schizophrenia. The compounds are also useful to lower IL-4, IL-5, or IL-15 levels in an animal.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: September 29, 2020
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl Wagner, Peter Jurutka, Pamela Marshall
  • Publication number: 20200171331
    Abstract: The present disclosure relates to pharmaceutical compositions comprising caffeic acid chelates, kits, and methods for using such compounds and pharmaceutical compositions.
    Type: Application
    Filed: May 8, 2018
    Publication date: June 4, 2020
    Inventors: Thomas Cahill, Jeffrey Langland, Bertram Jacobs, Carl Wagner, Guillermo Ruiz
  • Publication number: 20190218190
    Abstract: The invention provides compounds formula (I) and salts thereof: wherein R1-R4 have any of the values defined in the specification. The compounds are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, inflammation, hyperresponsiveness, allergic conditions, asthma, and psychotic disorders such as schizophrenia. The compounds are also useful to lower IL-4, IL-5, or IL-15 levels in an animal.
    Type: Application
    Filed: January 15, 2019
    Publication date: July 18, 2019
    Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl WAGNER, Peter JURUTKA, Pamela MARSHALL
  • Patent number: 10328040
    Abstract: The invention provides a method for a disease or condition associated with dopamine deficiency (e.g. depression, schizophrenia, or Parkinson's disease) in a mammal in need of such treatment comprising administering a compound that binds to RXR to the mammal.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: June 25, 2019
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Pamela Marshall, Peter Jurutka, Carl Wagner
  • Patent number: 10221143
    Abstract: The invention provides alkyl benzene compounds. The compounds are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, inflammation, hyperresponsiveness, allergic conditions, asthma, and psychotic disorders such as schizophrenia. The compounds are also useful to lower IL-4, IL-5, or IL-15 levels in an animal.
    Type: Grant
    Filed: March 1, 2016
    Date of Patent: March 5, 2019
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl Wagner, Peter Jurutka, Pamela Marshall
  • Patent number: 10112917
    Abstract: The invention provides compounds formula (I) and salts thereof: wherein the bond represented by ---- is a single bond or a double bond, and R1 has any of the values defined in the specification. The compounds are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, and psychotic disorders such as schizophrenia.
    Type: Grant
    Filed: March 1, 2016
    Date of Patent: October 30, 2018
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl Wagner, Peter Jurutka, Pamela Marshall
  • Patent number: 10005741
    Abstract: The invention provides compounds and compositions that are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, and psychotic disorders such as schizophrenia.
    Type: Grant
    Filed: January 17, 2018
    Date of Patent: June 26, 2018
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl Wagner, Pamela Marshall, Peter Jurutka
  • Patent number: 10003186
    Abstract: A variable-speed constant-frequency (VSCF) power converter includes a generator control operable to regulate an output voltage of a variable frequency generator at a variable frequency. The VSCF power generator also includes an inverter control operable to regulate a VSCF output voltage at a point-of-regulation at a constant frequency, where the generator control and the inverter control independently control a main line contactor of the point-of-regulation to provide redundant fault protection for an aircraft use.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: June 19, 2018
    Assignee: HAMILTON SUNDSTRAND CORPORATION
    Inventors: Carl A. Wagner, Mustansir Kheraluwala
  • Publication number: 20180141921
    Abstract: The invention provides compounds and compositions that are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, and psychotic disorders such as schizophrenia.
    Type: Application
    Filed: January 17, 2018
    Publication date: May 24, 2018
    Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl WAGNER, Pamela MARSHALL, Peter JURUTKA
  • Publication number: 20180072697
    Abstract: The invention provides compounds formula (I) and salts thereof: wherein the bond represented by ---- is a single bond or a double bond, and R1 has any of the values defined in the specification. The compounds are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, and psychotic disorders such as schizophrenia.
    Type: Application
    Filed: March 1, 2016
    Publication date: March 15, 2018
    Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl WAGNER, Peter JURUTKA, Pamela MARSHALL
  • Publication number: 20180065936
    Abstract: The invention provides compounds formula (I) and salts thereof: wherein R1-R4 have any of the values defined in the specification. The compounds are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, inflammation, hyperresponsiveness, allergic conditions, asthma, and psychotic disorders such as schizophrenia. The compounds are also useful to lower IL-4, IL-5, or IL-15 levels in an animal.
    Type: Application
    Filed: March 1, 2016
    Publication date: March 8, 2018
    Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl WAGNER, Peter JURUTKA, Pamela MARSHALL
  • Patent number: 9908856
    Abstract: The invention provides compounds and compositions that are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, and psychotic disorders such as schizophrenia.
    Type: Grant
    Filed: February 26, 2015
    Date of Patent: March 6, 2018
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl Wagner, Pamela Marshall, Peter Jurutka
  • Publication number: 20180011859
    Abstract: A networked database management system (DBMS) is disclosed. The DBMS may include a computer accessible data storage including a database, an access control module, a communication module, and a matching module. The database may be remotely located from a plurality of user nodes and a plurality of venue nodes. The remote database may include a plurality of records, wherein the records comprise: user node data, venue node data, and transaction data. The communication module may be in data communication with the data storage and may be configured to receive user node data and venue node data for storage in the database and query requests to retrieve user node data and venue node data from the database.
    Type: Application
    Filed: January 27, 2016
    Publication date: January 11, 2018
    Applicant: First-Hold, Inc.
    Inventors: Garry Hallinan, Carl Wagner, Jennifer Brown
  • Publication number: 20170365993
    Abstract: A variable-speed constant-frequency (VSCF) power converter includes a generator control operable to regulate an output voltage of a variable frequency generator at a variable frequency. The VSCF power generator also includes an inverter control operable to regulate a VSCF output voltage at a point-of-regulation at a constant frequency, where the generator control and the inverter control independently control a main line contactor of the point-of-regulation to provide redundant fault protection for an aircraft use.
    Type: Application
    Filed: June 15, 2016
    Publication date: December 21, 2017
    Inventors: Carl A. Wagner, Mustansir Kheraluwala
  • Patent number: 9664723
    Abstract: An arc fault detection system includes a first current sensor, a second current sensor, a band-pass filter, and a comparator module. The first current sensor, the second current sensor, and the comparator module are each connected to the comparator module by direct leads for biasing a current differential between the first current sensor and the second current sensor using a bias calculated from a frequency component indicative of arc events received from the frequency selector.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: May 30, 2017
    Assignee: Hamilton Sundstrand Corporation
    Inventors: Michael Krenz, Carl A. Wagner
  • Publication number: 20170008859
    Abstract: The invention provides compounds and compositions that are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, and psychotic disorders such as schizophrenia.
    Type: Application
    Filed: February 26, 2015
    Publication date: January 12, 2017
    Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Carl WAGNER, Pamela MARSHALL, Peter JURUTKA
  • Publication number: 20160338981
    Abstract: The invention provides a method for a disease or condition associated with dopamine deficiency (e.g. depression, schizophrenia, or Parkinson's disease) in a mammal in need of such treatment comprising administering a compound that binds to RXR to the mammal.
    Type: Application
    Filed: January 20, 2015
    Publication date: November 24, 2016
    Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Pamela MARSHALL, Peter JURUTKA, Carl WAGNER